Skip to content

Dr. Ann Collier



Co-PI of the TLC-ART program, Principal Investigator of the ACTU program

Phone: 206-744-3293






Ann Collier has been performing HIV-related clinical research for over 25 years with an emphasis on antiretroviral therapy and has conducted a wide variety of HIV clinical research studies, including investigator-initiated antiretroviral clinical trials, phase I-IV treatment protocols, and intensive pharmacokinetic studies. She has held leadership positions in four different NIH-funded, collaborative, HIV research groups, including chairing a committee responsible for the NIH-funded AIDS Clinical Trials Group’s antiretroviral treatment portfolio (including resource management) during the early 21st century. In addition, Ann has been a member of several Data Safety and Monitoring Boards for government and industry-sponsored clinical trials, including trials that had to be stopped early for safety reasons. She has recruited healthy HIV-uninfected volunteers for multiple pharmacokinetic and interventional studies. These experiences have provided her with extensive experience in antiretroviral drug development and opportunities for successful multidisciplinary collaborations. Additionally, Ann has directed a HIV treatment research site for over 25 years and has extensive experience in all aspects of the conduct of HIV-associated clinical trials and clinical care of persons with HIV infection. Her clinical experience in the conduct of antiretroviral treatment research, management of persons with HIV, expertise in and scientific leadership experience allows her to make valuable contributions to the TLC-ART program.